Medical-cannabis companies blast New York for ‘clear course for failure’ in state pot-business rollout

Indonesia Berita Berita

Medical-cannabis companies blast New York for ‘clear course for failure’ in state pot-business rollout
Indonesia Berita Terbaru,Indonesia Berita utama

Curaleaf, Green Thumb Industries, PharmaCann and Acreage argue that a proliferation of illegal shops and dangerous products is harming the state.

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

New York state’s largest medical-cannabis companies, which have been barred from wading into the adult-use market for more than two years, are saying they’ve waited long enough for licenses from the state.

While cannabis was legalized in the state more than two years ago, existing medical-pot companies have not been issued any permits, because the state is issuing its first licenses to social-equity applicants under its Conditional Adult-Use Retail Dispensary Program . Such a move could add up to 33 retail cannabis locations to those currently operating in the state and, they said, “provide a dependable supply of safe, tested cannabis products.”

In July, the state’s Office of Cannabis Management approved 212 CAURD licenses, bringing the total number of licenses in the state to 463.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

MarketWatch /  🏆 3. in İD
 

Indonesia Berita Terbaru, Indonesia Berita utama



Render Time: 2025-01-14 13:48:47